Iothalamate sodium - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for iothalamate sodium and what is the scope of patent protection?
Iothalamate sodium
is the generic ingredient in four branded drugs marketed by Mallinckrodt and Isotex, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.Summary for iothalamate sodium
US Patents: | 0 |
Tradenames: | 4 |
Applicants: | 2 |
NDAs: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 19 |
Clinical Trials: | 6 |
Patent Applications: | 996 |
Formulation / Manufacturing: | see details |
DailyMed Link: | iothalamate sodium at DailyMed |
Recent Clinical Trials for iothalamate sodium
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Mayo Clinic | Phase 2 |
National Institutes of Health (NIH) | Phase 1 |
National Heart, Lung, and Blood Institute (NHLBI) | Phase 1 |
US Patents and Regulatory Information for iothalamate sodium
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mallinckrodt | CONRAY 400 | iothalamate sodium | INJECTABLE;INJECTION | 014295-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mallinckrodt | CONRAY 325 | iothalamate sodium | INJECTABLE;INJECTION | 017685-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Isotex | GLOFIL-125 | iothalamate sodium i-125 | INJECTABLE;INJECTION | 017279-001 | Approved Prior to Jan 1, 1982 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mallinckrodt | ANGIO-CONRAY | iothalamate sodium | INJECTABLE;INJECTION | 013319-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |